株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

呼吸装置:医療機器のパイプライン評価

Respiratory Devices - Medical Devices Pipeline Assessment, 2017

発行 GlobalData 商品コード 351423
出版日 ページ情報 英文 564 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。
Back to Top
呼吸装置:医療機器のパイプライン評価 Respiratory Devices - Medical Devices Pipeline Assessment, 2017
出版日: 2017年10月01日 ページ情報: 英文 564 Pages
概要

当レポートでは、呼吸装置のパイプライン製品について調査しており、開発段階別の動向や製品の主要開発企業、現在継続中の治験、業界における最近の出来事などの情報をお届けします。

第1章 目次

第2章 イントロダクション

  • 呼吸装置の概要

第3章 開発中の製品

  • パイプライン製品:開発段階別
  • パイプライン製品:セグメント別
  • パイプライン製品:地域 (国) 別
  • パイプライン製品:規制経路別
  • パイプライン製品:承認時期別 (推定)
  • 継続中の治験

第4章 呼吸装置 - 開発中のパイプライン製品:企業別

  • 開発企業 - パイプライン製品:開発段階別
  • パイプライン製品:開発段階別

第5章 呼吸装置の開発企業と製品の概要

  • Ablynx NV
  • Advanced Brain Monitoring, Inc.
  • Advanced Circulatory Systems, Inc.
  • Afalapi
  • Airing LLC
  • Alaxo GmbH
  • Aloro Medical AB
  • ALung Technologies, Inc.
  • Anaxsys Technology Ltd
  • Baby's Breath Ltd.
  • Beijing Dehaier Medical Technology Co., Ltd.
  • Blucore Pty Ltd
  • Broncus Medical, Inc.
  • Cambridge Consultants Limited
  • Capnia, Inc.
  • Case Western Reserve University
  • Circadiance LLC
  • Cleveland Medical Devices, Inc.
  • Columbia Life Systems, Inc.
  • Creare Inc.
  • Deca-Medics, Inc.
  • DesignWise Medical Inc.
  • Discover Medical Device Ltd.
  • Endoclear LLC
  • Exploit Technologies Pte Ltd
  • Filtara, Inc.
  • Fisher & Paykel Healthcare Corporation Limited
  • GE Healthcare
  • GeNO, LLC
  • Haemair Limited
  • Hamilton Medical AG
  • Holaira, Inc.
  • INCA Medical Systems Ltd
  • Innovent Medical Solutions, Ltd.
  • Inogen, Inc.
  • inSleep Health
  • IntelliBreathe Ltd.
  • iSonea (Israel) Limited
  • Lehigh University
  • Liberate Medical, LLC
  • LifeServe Innovations, LLC
  • Lingua Flex, LLC
  • Lungpacer Medical Inc.
  • Marquette University
  • Massachusetts Institute of Technology
  • McGowan Institute for Regenerative Medicine
  • Medical Developments International Limited
  • Medivations Pty Ltd
  • Mergenet Medical, Inc.
  • Michigan Critical Care Consultants, Inc.
  • Miromatrix Medical Inc.
  • New Air, Inc.
  • NightBalance B.V.
  • Northwestern University
  • Noveko International Inc.
  • Nu-Med Plus, Inc.
  • OneBreath Inc.
  • PARI Pharma GmbH
  • Pavad Medical
  • Pharmagenix AG
  • Philips Healthcare
  • Pneumedicare Ltd.
  • Portaero
  • Pulmonx Corporation
  • Reactive Innovations, LLC
  • Respicardia, Inc.
  • RespiNova Ltd.
  • Respiratory Research, Inc.
  • Rhinomed Limited
  • Rice University
  • Rox Medical, Inc.
  • Sleep Secure LLC
  • SleepUp Ltd.
  • Smart Oxygen Solutions, Inc.
  • SolAeroMed Inc.
  • Spiration, Inc.
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • Stanford University
  • Stirling Pharma Inc
  • Tda Research Inc.
  • Tenax Therapeutics, Inc. (Inactive)
  • The Charles Stark Draper Laboratory Inc
  • The Johns Hopkins University
  • The University of Melbourne
  • TigerLAB
  • United Hayek Industries Inc.
  • United Therapeutics Corporation
  • Universitatsklinikum Freiburg
  • University of California, Los Angeles
  • University of California, San Diego
  • University of California, San Francisco
  • University of Kansas
  • University of Maryland, Baltimore
  • University of Michigan Pediatric Device Consortium
  • University of Missouri
  • University of Pittsburgh
  • University of Rochester
  • University of Texas Medical Branch at Galveston
  • Vivonics, Inc.
  • Wet Nose Technologies, LLC
  • Windmill Health Technologies Private Limited
  • Wyngate Medical Technologies, Inc.
  • Xenios AG
  • Xo Thermix Medical, Inc
  • Z-Cube S.r.l.
  • Zoll Medical Corporation

第6章 呼吸装置 - 最近の出来事

第7章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDME0458EPD

GlobalData's Medical Devices sector report, "Respiratory Devices - Medical Devices Pipeline Assessment, 2017" provides an overview of Respiratory Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Respiratory Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Respiratory Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Respiratory Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Respiratory Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 12
  • 1.2 List of Figures 21

2 Introduction 22

  • 2.1 Respiratory Devices Overview 22

3 Products under Development 25

  • 3.1 Respiratory Devices - Pipeline Products by Stage of Development 25
  • 3.2 Respiratory Devices - Pipeline Products by Segment 26
  • 3.3 Respiratory Devices - Pipeline Products by Territory 27
  • 3.4 Respiratory Devices - Pipeline Products by Regulatory Path 29
  • 3.5 Respiratory Devices - Pipeline Products by Estimated Approval Date 30
  • 3.6 Respiratory Devices - Ongoing Clinical Trials 31

4 Respiratory Devices - Pipeline Products under Development by Companies 32

  • 4.1 Respiratory Devices Companies - Pipeline Products by Stage of Development 32
  • 4.2 Respiratory Devices - Pipeline Products by Stage of Development 37

5 Respiratory Devices Companies and Product Overview 41

  • 5.1 Ablynx NV Company Overview 41
  • 5.2 Advanced Circulatory Systems Inc Company Overview 44
  • 5.3 AerovectRx Corporation Company Overview 45
  • 5.4 Afalapi Company Overview 46
  • 5.5 AFT Pharmaceuticals Ltd Company Overview 47
  • 5.6 Airing LLC Company Overview 48
  • 5.7 Alaxo GmbH Company Overview 49
  • 5.8 Aloro Medical AB Company Overview 52
  • 5.9 ALung Technologies Inc Company Overview 53
  • 5.10 Baby's Breath Ltd. Company Overview 58
  • 5.11 Beijing Dehaier Medical Technology Co Ltd Company Overview 60
  • 5.12 Blucore Pty Ltd Company Overview 63
  • 5.13 Breethe, Inc. Company Overview 64
  • 5.14 Broncus Medical Inc Company Overview 65
  • 5.15 Case Western Reserve University Company Overview 66
  • 5.16 Cleveland Medical Devices Inc Company Overview 67
  • 5.17 Coeo Labs Pvt Ltd Company Overview 68
  • 5.18 Columbia Life Systems, Inc. Company Overview 71
  • 5.19 Creare Inc Company Overview 72
  • 5.20 CSA Medical Inc Company Overview 73
  • 5.21 Deca-Medics Inc Company Overview 76
  • 5.22 DesignWise Medical Inc (Inactive) Company Overview 77
  • 5.23 Discover Medical Device Ltd (Inactive) Company Overview 79
  • 5.24 enmodes GmbH Company Overview 81
  • 5.25 Filtara, Inc. Company Overview 82
  • 5.26 Fisher & Paykel Healthcare Corporation Limited Company Overview 83
  • 5.27 GE Healthcare LLC Company Overview 88
  • 5.28 GeNO LLC Company Overview 89
  • 5.29 Hadassah Medical Center Company Overview 91
  • 5.30 Haemair Ltd Company Overview 92
  • 5.31 Hamilton Medical AG Company Overview 93
  • 5.32 HCi Viocare Technologies Ltd Company Overview 94
  • 5.33 Hill-Rom Holdings Inc Company Overview 95
  • 5.34 Innovent Medical Solutions Ltd Company Overview 97
  • 5.35 Inogen Inc Company Overview 100
  • 5.36 IntelliBreathe Ltd. Company Overview 101
  • 5.37 John Hopkins University Company Overview 102
  • 5.38 Koninklijke Philips N.V. Company Overview 103
  • 5.39 Lehigh University Company Overview 104
  • 5.40 Liberate Medical, LLC Company Overview 105
  • 5.41 LifeServe Innovations, LLC Company Overview 108
  • 5.42 Lingua Flex LLC Company Overview 110
  • 5.43 Lowenstein Medical Technology GmbH + Co. KG Company Overview 113
  • 5.44 Lung Biotechnology PBC Company Overview 114
  • 5.45 Lungpacer Medical Inc Company Overview 115
  • 5.46 Marquette University Company Overview 118
  • 5.47 Massachusetts Institute of Technology Company Overview 119
  • 5.48 McGowan Institute for Regenerative Medicine Company Overview 120
  • 5.49 MedArray Inc. Company Overview 122
  • 5.50 Medical Developments International Ltd Company Overview 123
  • 5.51 Medivations Pty Ltd Company Overview 125
  • 5.52 Mergenet Medical, Inc. Company Overview 126
  • 5.53 Merit Medical Systems Inc Company Overview 127
  • 5.54 Metamason Inc Company Overview 129
  • 5.55 Michigan Critical Care Consultants, Inc. Company Overview 131
  • 5.56 Miromatrix Medical Inc Company Overview 133
  • 5.57 mPhase Technologies, Inc. Company Overview 134
  • 5.58 Nanyang Technological University Company Overview 135
  • 5.59 Neonatal Rescue LLC Company Overview 136
  • 5.60 NightBalance BV Company Overview 138
  • 5.61 Ninox Medical Ltd Company Overview 141
  • 5.62 Noveko International Inc Company Overview 142
  • 5.63 Nu-Med Plus, Inc. Company Overview 144
  • 5.64 Nuvaira Inc Company Overview 147
  • 5.65 Olympus Medical Systems Corp Company Overview 151
  • 5.66 OneBreath Inc. Company Overview 155
  • 5.67 Parion Sciences Inc Company Overview 156
  • 5.68 Pavad Medical Company Overview 159
  • 5.69 Pharmagenix AG Company Overview 160
  • 5.70 Philips Healthcare Company Overview 161
  • 5.71 Pneumedicare Ltd. Company Overview 162
  • 5.72 Portaero Inc Company Overview 163
  • 5.73 Pulmonx Corp Company Overview 164
  • 5.74 Reactive Innovations, LLC Company Overview 170
  • 5.75 Respicardia Inc Company Overview 172
  • 5.76 RespiNova Ltd Company Overview 175
  • 5.77 Respira Ltd Company Overview 176
  • 5.78 Respiratory Research Inc Company Overview 179
  • 5.79 Respiri Ltd Company Overview 181
  • 5.80 Rhinomed Ltd Company Overview 185
  • 5.81 Rice University Company Overview 188
  • 5.82 Sensory Innovation Solutions Company Overview 189
  • 5.83 Sleep Secure LLC Company Overview 190
  • 5.84 SleepUp Ltd Company Overview 191
  • 5.85 Smart Oxygen Solutions, Inc. Company Overview 193
  • 5.86 SolAeroMed Inc Company Overview 194
  • 5.87 Sommetrics, Inc. Company Overview 195
  • 5.88 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 196
  • 5.89 Stanford University Company Overview 197
  • 5.90 Stirling Pharma Inc Company Overview 199
  • 5.91 Tda Research Inc. Company Overview 200
  • 5.92 Tenax Therapeutics Inc Company Overview 201
  • 5.93 The Charles Stark Draper Laboratory Inc Company Overview 202
  • 5.94 The Pennsylvania State University Company Overview 204
  • 5.95 TigerLAB Company Overview 205
  • 5.96 United Hayek Industries Inc. Company Overview 206
  • 5.97 University Hospital Freiburg Company Overview 207
  • 5.98 University of Arizona Company Overview 208
  • 5.99 University of California Davis Company Overview 209
  • 5.100 University of California Los Angeles Company Overview 210
  • 5.101 University of California San Diego Company Overview 213
  • 5.102 University of California San Francisco Company Overview 215
  • 5.103 University of Illinois at Chicago Company Overview 219
  • 5.104 University of Kansas Company Overview 220
  • 5.105 University of Melbourne Company Overview 222
  • 5.106 University of Michigan Company Overview 223
  • 5.107 University of Michigan Pediatric Device Consortium Company Overview 224
  • 5.108 University of Missouri Company Overview 227
  • 5.109 University of Pittsburgh Company Overview 228
  • 5.110 University of Rochester Company Overview 229
  • 5.111 University of Texas Medical Branch at Galveston Company Overview 230
  • 5.112 Ventec Life Systems Inc Company Overview 231
  • 5.113 Verona Pharma Plc Company Overview 233
  • 5.114 Vivaspire Inc Company Overview 237
  • 5.115 Xenios AG Company Overview 238
  • 5.116 Xo Thermix Medical, Inc Company Overview 240
  • 5.117 Z-Cube Srl Company Overview 241

6 Respiratory Devices- Recent Developments 242

  • 6.1 Sep 19, 2017: Adherium Appoints New CFO 242
  • 6.2 Sep 18, 2017: Real-World Data Confirms Long-Term Effectiveness Of Bronchial Thermoplasty 242
  • 6.3 Sep 18, 2017: Teladoc Appoints Former Pandora CEO Brian McAndrews to Board of Directors 243
  • 6.4 Sep 11, 2017: CSA Medical Presented Early Clinical Data on the RejuvenAir Metered Cryospray System at the European Respiratory Society Conference 2017 244
  • 6.5 Sep 08, 2017: Endobronchial valve treatment appears to improve lung function in patients with severe emphysema 244
  • 6.6 Sep 08, 2017: CSA Medical will Host a Mini-Symposium featuring the RejuvenAir Metered Cryospray System at the European Respiratory Society Conference 245
  • 6.7 Sep 08, 2017: New Study Demonstrates Zephyr Endobronchial Valves Significantly Improve Breathing, Mobility and Quality of Life for Emphysema Patients 246
  • 6.8 Sep 07, 2017: Nuvaira Announces Four Clinical Abstracts Accepted For Presentation At Ers International Congress 247
  • 6.9 Sep 06, 2017: InterVapor Bronchoscopic Thermal Vapor Ablation is Back on the Market English 248
  • 6.10 Sep 06, 2017: Vectura Group: 2017 Interim Results 248
  • 6.11 Sep 06, 2017: MGC Diagnostics Reports Fiscal 2017 Third Quarter Results 250
  • 6.12 Sep 06, 2017: Enzymatica recruits Chief Financial Officer 251
  • 6.13 Sep 05, 2017: Insmed Announces Positive Top-Line Results from Phase 3 CONVERT Study of ALIS (Amikacin Liposome Inhalation Suspension) in Adult Patients with Treatment-Refractory Nontuberculous Mycobacterial Lung Disease Caused by Mycobacterium Avium Complex 252
  • 6.14 Sep 05, 2017: Soleno Therapeutics Announces CFO Transition 253
  • 6.15 Sep 05, 2017: Electromed Announces Fiscal 2017 Fourth Quarter Financial Results 254
  • 6.16 Sep 04, 2017: Uptake Medicals BTVA has best safety profile per German Institute for Quality and Efficiency in Healthcare (IQWiG) 255
  • 6.17 Sep 01, 2017: Adherium Receives U.S. 510(K) Clearance for Next Generation Smartinhaler for AstraZeneca's Symbicort Aerosol Inhaler 256
  • 6.18 Aug 30, 2017: GSK responds to UK Life Sciences Industrial Strategy 257
  • 6.19 Aug 25, 2017: RespireRx Pharmaceuticals Files June 30, 2017 Quarterly Report on Form 10-Q And Provides Update 257
  • 6.20 Aug 24, 2017: OSI Systems Reports Fourth Quarter and Fiscal 2017 Financial Results 259
  • 6.21 Aug 23, 2017: Curacao EMS Uses ZOLL AutoPulse to Save Tourist in Sudden Cardiac Arrest 260
  • 6.22 Aug 23, 2017: Ambu: Interim Report Q3 2016/17 260
  • 6.23 Aug 23, 2017: Henry Ford Hospital CEO Announces Retirement 261
  • 6.24 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 262
  • 6.25 Aug 21, 2017: Teladoc Adds David Schloss as Chief Human Resources Officer 264
  • 6.26 Aug 21, 2017: Invacare Appoints Barbara Bodem to Board of Directors 265
  • 6.27 Aug 17, 2017: Adherium Hits 100,000 Smartinhaler Commercial Milestone 265
  • 6.28 Aug 17, 2017: Palo Alto Health Sciences Names Amy Perry to Board of Directors 266
  • 6.29 Aug 16, 2017: Global development agreement with Dynavax for lung cancer programme using Vectura's smart nebuliser technology (VR347) 266
  • 6.30 Aug 11, 2017: Cipla Announces Q1FY 18 Results 267
  • 6.31 Aug 08, 2017: BioLineRx announces Q2 2017 Financial Results 267
  • 6.32 Aug 07, 2017: Invacare Reports Results for Second Quarter 2017 269
  • 6.33 Aug 03, 2017: Teleflex Reports Second Quarter 2017 Results 271
  • 6.34 Aug 03, 2017: Inogen Announces Record Second Quarter 2017 Financial Results 273
  • 6.35 Aug 03, 2017: Getinge to cooperate with Brazilian authorities on local ongoing investigations 275
  • 6.36 Aug 02, 2017: Cardinal Health Reports Q4 and Fiscal 2017 Results, Provides 2018 Guidance 275
  • 6.37 Aug 02, 2017: Teladoc Announces Second Quarter 2017 Results 277
  • 6.38 Aug 02, 2017: Masimo Reports Second Quarter 2017 Financial Results 277
  • 6.39 Aug 02, 2017: Boehringer Ingelheim Achieves Good Growth in the First Half of 2017 278
  • 6.40 Aug 01, 2017: Owens & Minor Reports 2nd Quarter 2017 Financial Results 279
  • 6.41 Aug 01, 2017: ResMed Announces Results for the Fourth Quarter of Fiscal Year 2017 281
  • 6.42 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 282
  • 6.43 Jul 27, 2017: United Therapeutics Reports Second Quarter 2017 Financial Results 284
  • 6.44 Jul 26, 2017: Verona Pharma Doses First Patients in Phase 2b Clinical Trial of RPL554 for COPD Maintenance Treatment 286
  • 6.45 Jul 26, 2017: GSK delivers further progress in Q2 and sets out new priorities for the Group 287
  • 6.46 Jul 25, 2017: Karenann Terrell appointed Chief Digital & Technology Officer, GSK 293
  • 6.47 Jul 25, 2017: Catherine Estrampes appointed President & CEO of GE Healthcare Europe 293
  • 6.48 Jul 25, 2017: 3M Delivers Second-Quarter Sales of $7.8 Billion and Earnings of $2.58 per Share; Company Updates Its 2017 Outlook 294
  • 6.49 Jul 25, 2017: Utah Medical Products Reports Financial Performance for Second Quarter 2017 296
  • 6.50 Jul 21, 2017: GSK announces Board and Committee changes 300
  • 6.51 Jul 20, 2017: Enzymatica Q2 loss down 300
  • 6.52 Jul 18, 2017: Enzymatica recruits Chief Commercial Officer 300
  • 6.53 Jul 17, 2017: Getinge appoints Lars Sandstrom as CFO and Member of Getinge Executive Team 301
  • 6.54 Jul 17, 2017: Getinge has replanned the remediation in Hechingen (DE) related to the Consent Decree with FDA and makes a provision of additional SEK 488 M 302
  • 6.55 Jul 17, 2017: Getinge: Interim Report January - June 2017 302
  • 6.56 Jul 14, 2017: Enzymatica recruits Chief Operating Officer 302
  • 6.57 Jul 10, 2017: Philips-sponsored study suggests positive airway pressure therapy could reduce COPD patient hospitalization 303

7 Appendix 559

  • 7.1 Methodology 559
  • 7.2 About GlobalData 562
  • 7.3 Contact Us 562
  • 7.4 Disclaimer 562

List of Tables

1.1 List of Tables

  • Table 1: Respiratory Devices - Pipeline Products by Stage of Development 27
  • Table 2: Respiratory Devices - Pipeline Products by Segment 28
  • Table 3: Respiratory Devices - Pipeline Products by Territory 30
  • Table 4: Respiratory Devices - Pipeline Products by Regulatory Path 31
  • Table 5: Respiratory Devices - Pipeline Products by Estimated Approval Date 32
  • Table 6: Respiratory Devices - Ongoing Clinical Trials 33
  • Table 7: Respiratory Devices Companies - Pipeline Products by Stage of Development 34
  • Table 8: Respiratory Devices - Pipeline Products by Stage of Development 39
  • Table 9: Ablynx NV Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 10: Customised Infant Inhalation Device - Product Status 43
  • Table 11: Customised Infant Inhalation Device - Product Description 43
  • Table 12: Ablynx NV - Ongoing Clinical Trials Overview 44
  • Table 13: Customised Infant Inhalation Device - A Randomized, Double-blind, Placebo-controlled, Multicenter Dose Ranging Study of ALX-0171 in Infants and Young Children Hospitalized for Respiratory Syncytial Virus Lower Respiratory Tract Infection 45
  • Table 14: Advanced Circulatory Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 15: ResQVENT - Product Status 46
  • Table 16: ResQVENT - Product Description 46
  • Table 17: AerovectRx Corporation Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 18: Aerocurrent - Product Status 47
  • Table 19: Aerocurrent - Product Description 47
  • Table 20: Afalapi Pipeline Products & Ongoing Clinical Trials Overview 48
  • Table 21: Variable Positive Air Pressure (VPAP) Device - Product Status 48
  • Table 22: Variable Positive Air Pressure (VPAP) Device - Product Description 48
  • Table 23: AFT Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 24: NasoSURF - Product Status 49
  • Table 25: NasoSURF - Product Description 49
  • Table 26: Airing LLC Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 27: Airing Device - Product Status 50
  • Table 28: Airing Device - Product Description 50
  • Table 29: Alaxo GmbH Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 30: AlaxoLito Nasal Stent - Product Status 51
  • Table 31: AlaxoLito Nasal Stent - Product Description 51
  • Table 32: AlaxoLito Plus Nasal Stent - Product Status 52
  • Table 33: AlaxoLito Plus Nasal Stent - Product Description 52
  • Table 34: AlaxoStent - Product Status 52
  • Table 35: AlaxoStent - Product Description 53
  • Table 36: Aloro Medical AB Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 37: Closed Breathing System - Product Status 54
  • Table 38: Closed Breathing System - Product Description 54
  • Table 39: ALung Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 40: Hattler Catheter - Product Status 55
  • Table 41: Hattler Catheter - Product Description 55
  • Table 42: Hemolung RAS - Product Status 56
  • Table 43: Hemolung RAS - Product Description 56
  • Table 44: ALung Technologies Inc - Ongoing Clinical Trials Overview 57
  • Table 45: Hemolung RAS - A Pivotal Clinical Study of Hemolung Respiratory Assist System in Treatment of Patients with Chronic Obstructive Pulmonary Disease 58
  • Table 46: Hemolung RAS - Extra-corporeal CO2 Removal as an Adjunct to Non-Invasive Ventilation in Acute Severe Exacerbations of COPD 58
  • Table 47: Hemolung RAS - Physiological Study of Minimally Invasive Extracorporeal CO2 Removal in Exacerbations of COPD Requiring Invasive Mechanical Ventilation 58
  • Table 48: Hemolung RAS - Protective Ventilation with Veno-venous Lung Assist in Respiratory Failure 59
  • Table 49: Baby's Breath Ltd. Pipeline Products & Ongoing Clinical Trials Overview 60
  • Table 50: Ultrasonic Compressor - Product Status 60
  • Table 51: Ultrasonic Compressor - Product Description 60
  • Table 52: WiseAir - Product Status 61
  • Table 53: WiseAir - Product Description 61
  • Table 54: Beijing Dehaier Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 62
  • Table 55: DHR-A8 Auto Continuous Positive Airway Pressure Device - Product Status 62
  • Table 56: DHR-A8 Auto Continuous Positive Airway Pressure Device - Product Description 62
  • Table 57: High-Efficiency Oxygen Inhaler - Product Status 63
  • Table 58: High-Efficiency Oxygen Inhaler - Product Description 63
  • Table 59: Second Generation CPAP Device - Product Status 63
  • Table 60: Second Generation CPAP Device - Product Description 64
  • Table 61: Second Generation Oxygen Concentrator - Product Status 64
  • Table 62: Second Generation Oxygen Concentrator - Product Description 64
  • Table 63: Blucore Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 65
  • Table 64: Breathing Device - Product Status 65
  • Table 65: Breathing Device - Product Description 65
  • Table 66: Breethe, Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
  • Table 67: OXY-1 - Product Status 66
  • Table 68: OXY-1 - Product Description 66
  • Table 69: Broncus Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 67
  • Table 70: Exhale Drug Eluting Stent - Product Status 67
  • Table 71: Exhale Drug Eluting Stent - Product Description 67
  • Table 72: Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview 68
  • Table 73: Portable Artificial Lung - Product Status 68
  • Table 74: Portable Artificial Lung - Product Description 68
  • Table 75: Cleveland Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 69
  • Table 76: Auto-Titrating CPAP - Product Status 69
  • Table 77: Auto-Titrating CPAP - Product Description 69
  • Table 78: Coeo Labs Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 70
  • Table 79: VAPCare - Product Status 70
  • Table 80: VAPCare - Product Description 70
  • Table 81: Coeo Labs Pvt Ltd - Ongoing Clinical Trials Overview 71
  • Table 82: VAPCare - A Preliminary Observational Study to Characterize Pattern of Pooling and Physical Properties of Secretions in Oral and Oropharyngeal Area in Patients on Ventilator Care 72
  • Table 83: Columbia Life Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 73
  • Table 84: SmartBlender - Product Status 73
  • Table 85: SmartBlender - Product Description 73
  • Table 86: Creare Inc Pipeline Products & Ongoing Clinical Trials Overview 74
  • Table 87: DDC-Based Nebulizer - Product Status 74
  • Table 88: DDC-Based Nebulizer - Product Description 74
  • Table 89: CSA Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 75
  • Table 90: RejuvenAir Metered Cryospray System - Product Status 75
  • Table 91: RejuvenAir Metered Cryospray System - Product Description 75
  • Table 92: CSA Medical Inc - Ongoing Clinical Trials Overview 76
  • Table 93: RejuvenAir Metered Cryospray System - A Prospective Safety and Feasibility Study of the RejuvenAir System Metered Cryospray Therapy for Chronic Bronchitis Patients 77
  • Table 94: Deca-Medics Inc Pipeline Products & Ongoing Clinical Trials Overview 78
  • Table 95: LifeBelt - CPR - Product Status 78
  • Table 96: LifeBelt - CPR - Product Description 78
  • Table 97: DesignWise Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 79
  • Table 98: OPOD System - Product Status 79
  • Table 99: OPOD System - Product Description 79
  • Table 100: Self-Contained Nebulizer System - Product Status 80
  • Table 101: Self-Contained Nebulizer System - Product Description 80
  • Table 102: Discover Medical Device Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 81
  • Table 103: SomnuSeal CPAP Mask - Product Status 81
  • Table 104: SomnuSeal CPAP Mask - Product Description 81
  • Table 105: SomnuSeal CPAP Mask Version 2.0 - Product Status 82
  • Table 106: SomnuSeal CPAP Mask Version 2.0 - Product Description 82
  • Table 107: enmodes GmbH Pipeline Products & Ongoing Clinical Trials Overview 83
  • Table 108: RAS-Q - Product Status 83
  • Table 109: RAS-Q - Product Description 83
  • Table 110: Filtara, Inc. Pipeline Products & Ongoing Clinical Trials Overview 84
  • Table 111: Lightweight Medical Oxygen Device - Product Status 84
  • Table 112: Lightweight Medical Oxygen Device - Product Description 84
  • Table 113: Fisher & Paykel Healthcare Corporation Limited Pipeline Products & Ongoing Clinical Trials Overview 85
  • Table 114: F&P 950 Heated Humidification System - Product Status 85
  • Table 115: F&P 950 Heated Humidification System - Product Description 86
  • Table 116: SleepStyle CPAP Device - Product Status 86
  • Table 117: SleepStyle CPAP Device - Product Description 86
  • Table 118: Fisher & Paykel Healthcare Corporation Limited - Ongoing Clinical Trials Overview 87
  • Table 119: F&P 950 Heated Humidification System - Humidification Needs 88
  • Table 120: SleepStyle CPAP Device - Randomized Trial Comparing CPAP Machines with Reusable Versus Disposable Circuits 89
  • Table 121: GE Healthcare LLC Pipeline Products & Ongoing Clinical Trials Overview 90
  • Table 122: Ventilator - Neonates - Product Status 90
  • Table 123: Ventilator - Neonates - Product Description 90
  • Table 124: GeNO LLC Pipeline Products & Ongoing Clinical Trials Overview 91
  • Table 125: GeNOSYL Nitrosyl Delivery Platform - Ambulatory System - Product Status 91
  • Table 126: GeNOSYL Nitrosyl Delivery Platform - Ambulatory System - Product Description 91
  • Table 127: NITROSYL System - Product Status 92
  • Table 128: NITROSYL System - Product Description 92
  • Table 129: Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 93
  • Table 130: ThoraXS - Product Status 93
  • Table 131: ThoraXS - Product Description 93
  • Table 132: Haemair Ltd Pipeline Products & Ongoing Clinical Trials Overview 94
  • Table 133: Portable Artificial Lung - Product Status 94
  • Table 134: Portable Artificial Lung - Product Description 94
  • Table 135: Hamilton Medical AG Pipeline Products & Ongoing Clinical Trials Overview 95
  • Table 136: HAMILTON-MR1 Neonatal - Product Status 95
  • Table 137: HAMILTON-MR1 Neonatal - Product Description 95
  • Table 138: HCi Viocare Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 96
  • Table 139: Sleep apnea device (BiPAP) - Product Status 96
  • Table 140: Sleep apnea device (BiPAP) - Product Description 96
  • Table 141: Hill-Rom Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 97
  • Table 142: Mobile Vest Clearance System - Product Status 97
  • Table 143: Mobile Vest Clearance System - Product Description 98
  • Table 144: Innovent Medical Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 99
  • Table 145: Home Respiratory Clearance System - Product Status 99
  • Table 146: Home Respiratory Clearance System - Product Description 99
  • Table 147: Innovent System - Product Status 100
  • Table 148: Innovent System - Product Description 100
  • Table 149: Second Generation Device - Product Status 100
  • Table 150: Second Generation Device - Product Description 101
  • Table 151: Inogen Inc Pipeline Products & Ongoing Clinical Trials Overview 102
  • Table 152: Inogen One G4 - Product Status 102
  • Table 153: Inogen One G4 - Product Description 102
  • Table 154: IntelliBreathe Ltd. Pipeline Products & Ongoing Clinical Trials Overview 103
  • Table 155: Mask-Free Sleep Apnea System With Controlled Air Supply - Product Status 103
  • Table 156: Mask-Free Sleep Apnea System With Controlled Air Supply - Product Description 103
  • Table 157: John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 104

List of Figures

1.2 List of Figures

  • Figure 1: Respiratory Devices - Pipeline Products by Stage of Development 27
  • Figure 2: Respiratory Devices - Pipeline Products by Territory 29
  • Figure 3: Respiratory Devices - Pipeline Products by Regulatory Path 31
  • Figure 4: Respiratory Devices - Pipeline Products by Estimated Approval Date 32
  • Figure 5: Respiratory Devices - Ongoing Clinical Trials 33
Back to Top